PTH-82 Alcam, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer

Yiming Yang,Andrew J. Sanders,Jiafu Ji,Ke Ji,Shuqin Jia,Wen G. Jiang
DOI: https://doi.org/10.1136/gutjnl-2021-bsg.261
IF: 24.5
2021-01-01
Gut
Abstract:Introduction ALCAM, activated leukocyte cell adhesion molecule (also known as CD166) is a cell surface adhesive ‘soil receptor’, conferring heterotypic and homotypic cell-cell adhesions, and has been shown to have a possible role in cell-cell adhesion and has been indicated in the development and progression of certain solid tumours. We explored the clinical and prognostic significance of ALCAM in clinical gastric cancer. Methods A cohort of three hundred and sixteen gastric cancers (including one hundred and eighty two pairs of tumour and normal tissues) were freshly collected from patients immediately after surgery resection of primary gastric cancer. The ALCAM gene transcripts were quantified in both normal and tumour tissues and the transcript levels were analysed against clinical outcome, clinical and pathological factors of the patients. Statistics were Log rank survival analyses, logical regression and Mann-Whitney U tests. Results Tumour tissues, particularly late stage tumours had higher levels of ALCAM than normal tissues. Patients bearing tumours with high levels of ALCAM transcripts had a significantly shorter overall survival (55.9±3.5 months versus 43.4±2.7 months, low versus high levels, p=0.043, Hazard Ratio (HR 1.67)). Likewise, patients with high levels of ALCAM had shorter disease free survival (Hazard Ratio 1.43). High levels of ALCAM in gastric tumours seen in those that had invaded whole muscular layer and serosa of the stomach. It was discovered that ALCAM levels were markedly correlated with the levels of the Her family members (p<0.0001 for all 4 family members EGFR (Her1 or ErbB1), Her2 (ErbB2), Her3 (ErbB3) and Her4 (ErbB4)) and that together with Her4, ALCAM had an independent value in predicting the death of the patients. Conclusions Activated leukocyte cell adhesion molecule, ALCAM, has an important prognostic value in patients with gastric cancer and may present as a potential anti-cancer target in this cancer type.
What problem does this paper attempt to address?